Dapsone
Back to searchMolecule Structure
Scientific Name
Dapsone
Description of the Drug
Dapsone is a sulfone drug used to treat acne vulgaris, Hansen’s disease, and dermatitis herpetiformis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00250
http://www.drugbank.ca/drugs/DB00250
Brand Name(s)
Aczone, Dapsone
Company Owner(s)
Nostrum Laboratories Inc, Jacobus Pharmaceutical Co, Novitium Pharma Llc, Alvogen Inc, Actavis Llc, Taro Pharmaceuticals Usa Inc, Almirall Llc, Mylan Pharmaceuticals Inc, Taro Pharmaceutical Industries Ltd, Virtus Pharmaceuticals Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dihydropteroate synthase 1 | SINGLE PROTEIN | INHIBITOR | CHEMBL2362993 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL21428 | |||
| PharmGKB | PA449211 | |||
| Human Metabolome Database | HMDB0014395 | |||
| DrugBank | DB00250 | |||
| PubChem: Thomson Pharma | 15196656 | |||
| PubChem | 2955 | |||
| Mcule | MCULE-7294380437 | |||
| LINCS | LSM-5714 | |||
| Nikkaji | J4.247A | |||
| BindingDB | 50029764 | |||
| EPA CompTox Dashboard | DTXSID4020371 | |||
| DrugCentral | 782 | |||
| Brenda | 91595 | 3721 | 25832 | 44033 |
| ChemicalBook | CB0152851 | |||
| Guide to Pharmacology | 10934 | |||
| rxnorm | DAPSONE | ACZONE | ||
| PubChem: Drugs of the Future | 24714727 | |||
| KEGG Ligand | C07666 | |||
| ChEBI | 4325 | |||
| ZINC | ZINC000000006310 |
